IBB

Recent Articles

The iShares Nasdaq Biotechnology Index (ETF) (IBB) — It’s Make-or-Break Time

While the intermediate-term trend remains intact for the IBB etf, earnings season for large biotech companies could be make-or-break. More 

The iShares Nasdaq Biotechnology Index (ETF) (IBB): Gravity Calls!

Active investors and traders should look to play the iShares Nasdaq Biotechnology Index (ETF) (IBB) to the short side until the picture changes. More 

Biotech Bloodbath: Ditch XBI, IBB for Now

Biotech ETFs IBB and XBI are in a hurt locker right now. Even if you're bullish on biotechs for the long-term, consider a hedge play or two for now. More 

IBB: The iShares NASDAQ Biotechnology Index (ETF) Is Still a Buy

Even if Hillary Clinton becomes the next POTUS, biotech stocks won't sink into oblivion -- that's enough reason to buy the IBB ETF. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB): Just Short It!

The biotech sector has had its ups and downs, but I think there are more downs to come. Short IBB for free. More 

Trade of the Day: IBB Breaking Down

Some notable technical damage favors more downside in iShares NASDAQ Biotechnology Index (ETF). More 

Weight of Evidence Points to Stocks Heading Lower

At the very least, the market has limited upside from here. More